HMHaruhisa Matsuguma

Haruhisa Matsuguma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haruhisa Matsuguma has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparison of Three Measurements on Computed Tomography for the Prediction of Less Invasiveness in Patients With Clinical Stage I Non–Small Cell Lung Cancer

    by Haruhisa Matsuguma, Izumi Oki, Rie Nakahara, Haruko Suzuki, Takashi Kasai, Yukari Kamiyama, Seiji Igarashi, Kiyoshi Mori, Shunsuke Endo, Kohei Yokoi


  • Characteristics of Subsolid Pulmonary Nodules Showing Growth During Follow-up With CT Scanning

    by Haruhisa Matsuguma, Kiyoshi Mori, Rie Nakahara, Haruko Suzuki, Takashi Kasai, Yukari Kamiyama, Seiji Igarashi, Tetsuro Kodama, Kohei Yokoi


  • Open Access

    Reply to Jiwnani et al.

    by Haruhisa Matsuguma, Kohei Yokoi

    We thank Jiwnani et al. [1] for their interest in and comments regarding our recently published paper, outlining a new nodal classification based on the number of metastatic lymph nodes (LNs) or the ratio of metastatic to examined LNs (LNR) [2]. As we realized that the concerns raised by Jiwnani et al. are the main issues in our article, we specifically addressed these concerns in the discussion of our original article. We will discuss these issues one by one in more detail. With regard to the unreliability of new nodal classifications, as Jiwnani et al. correctly note, the number of metastatic LNs and LNR are influenced by the method of LN removal and the diligence of the pathologist examining the specimen. Therefore, a standardized method in nodal dissection and the pathological process should be established for a new nodal classification. This includes the minimum number of LNs to remove, as in the current nodal classification for stomach, colorectal and breast cancer. Regarding LNR, many surgeons may feel that LNR is less reliable than the number of metastatic LNs, because the ratio can widely vary if only a small number of LNs are examined. For example, one metastatic LN out of one examined LN is 100%, but one out of two is 50%. Therefore, we again emphasize establishing a standardized method of LN sampling. However, when established, LNR can be superior to the number of examined LNs because LNR includes an implication of the number of the examined LNs, which has been demonstrated to be a prognostic factor [3, 4]. Concerning the fragmentation of removed LNs, we think that this may be a specific characteristic of lung cancer operations. To resolve this matter, Wei et al. [5] proposed putting the fragments from one single LN into the same bottle and treating it as one LN. In addition, as outlined in our original discussion, the nodal classification based on LNR may be more stable than the nodal classification based on the number of metastatic LNs. This is because both the numerator and denominator of the calculation formula of LNR will increase at an equal rate, if fragmentation occurs in metastatic and non-metastatic LNs. Regarding clinical staging, we advocate that our proposed nodal staging system should be used in a postoperative setting to select more effective adjuvant treatment candidates. Therefore, we suggest that clinical and pathological staging be conducted separately as the TNM classification for breast cancer. Even if new nodal staging increases complexity, if a new nodal staging system can provide a better indicator to classify patients according to their probability of recurrence, adjuvant therapy can be more efficiently applied to more appropriate patients, and be associated with the improvement of survival. In this situation, we believe that the new nodal staging system will be supported and followed by most physicians and pathologists.

  • Is There a Role for Pulmonary Metastasectomy With a Curative Intent in Patients With Metastatic Urinary Transitional Cell Carcinoma?

    by Haruhisa Matsuguma, Ichiro Yoshino, Hideyuki Ito, Tomoyuki Goya, Yukiko Matsui, Jun Nakajima, Norihiko Ikeda, Sakae Okumura, Satoshi Shiono, Hiroaki Nomori


  • Open Access

    Proposal of new nodal classifications for non-small-cell lung cancer based on the number and ratio of metastatic lymph nodes

    by Haruhisa Matsuguma, Izumi Oki, Rie Nakahara, Norihisa Ohata, Seiji Igarashi, Kiyoshi Mori, Shunsuke Endo, Kohei Yokoi

    The study aimed to evaluate the effectiveness of two new nodal classifications based on the number of metastatic lymph nodes (LNs) or ratio of metastatic to examined LNs (LNR) in making a prognosis, compared with the current nodal classification based on the location of metastatic LNs. We analyzed 651 non-small-cell lung cancer patients who had undergone complete resection with the removal of more than five LNs between 1986 and 2003, excluding preoperative treatment cases, and a Tis, T4, N3, and M1 status, along with limited resection and operative death cases. The cutoff numbers for each category in the two new nodal classifications (number of metastatic LNs (nN0–2): 0, 1–2, and >3, and LNR (rN0–2): 0, 1–12, and >12%) were defined so that the numbers corresponded with paired categories within the current nodal classification. The 5-year survival rate was 75.4% for patients with the N0 categories in all three classifications. The 5-year survival rates for patients with N1 and N2 categories were 52.2% and 42.6% according to the current nodal classification, 54.3% and 39.8% according to the number of metastatic LNs, and 58.8% and 35.0% according to the LNR, respectively. Although all three nodal classifications were independent prognostic factors along with the age and pathological T status, when the three nodal classifications were entered into multivariate analysis individually, the hazard ratio of rN2 was the highest, at 3.15, followed by that of nN2 at 2.96. The LNR followed by the number of metastatic LNs may be more effective prognostic indicators than the current nodal classification based on the location of metastatic LNs. For the future revision, the number of metastatic LNs and LNR should be evaluated as indicators for the nodal classification of lung cancer.


  • Transmanubrial osteomuscular sparing approach for lung cancer invading the anterior part of the thoracic inlet

    by Haruhisa Matsuguma, Rie Nakahara, Yoshinori Ishikawa, Haruko Suzuki, Akiko Ui, Kohei Yokoi

    Standard treatment for lung cancer presenting as a superior sulcus tumor is induction chemoradiotherapy followed by surgery, which yields rates of about 70% complete resection and 50% 5-year survival rate. However, the surgical technique to achieve complete resection for superior sulcus tumor invading major anatomical sites including the subclavian artery is challenging. The anterior transcervical thoracic approach applied by Dartevelle and colleagues provides excellent exposure of the subclavian vessels. Grunenwald and associates have improved on this approach to preserve the clavicle and sternoclavicular joint. We applied the transmanubrial osteomuscular-sparing approach in two patients. In both cases, exposure of the subclavian vessels was excellent. In one case, the subclavian artery was resected and reconstructed with a polytetrafl uoroethylene graft. This patient has continued to show recurrence-free survival for more than 5 years. We outline our experience and review the literature on the surgical approach for superior sulcus tumor invading the anterior part of the thoracic inlet.